NMRA Annual Shareholders Equity
$469.08 M
+$915.93 M+204.97%
31 December 2023
Summary:
As of January 23, 2025, NMRA annual stockholders equity is $469.08 million, with the most recent change of +$915.93 million (+204.97%) on December 31, 2023. During the last 3 years, it has risen by +$563.46 million (+596.99%). NMRA annual shareholders equity is now at all-time high.NMRA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRA Quarterly Shareholders Equity
$320.74 M
-$60.52 M-15.87%
30 September 2024
Summary:
As of January 23, 2025, NMRA quarterly stockholders equity is $320.74 million, with the most recent change of -$60.52 million (-15.87%) on September 30, 2024. Over the past year, it has dropped by -$103.80 million (-24.45%). NMRA quarterly shareholders equity is now -37.44% below its all-time high of $512.69 million, reached on September 30, 2023.NMRA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +205.0% | -24.4% |
| 3 y3 years | +597.0% | +181.3% |
| 5 y5 years | +10000.0% | +181.3% |
NMRA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +205.0% | -37.4% | +162.5% |
| 5 y | 5-year | at high | +205.0% | -37.4% | +162.5% |
| alltime | all time | at high | +205.0% | -37.4% | +162.5% |
Neumora Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $320.74 M(-15.9%) |
| June 2024 | - | $381.26 M(-10.2%) |
| Mar 2024 | - | $424.54 M(-9.5%) |
| Dec 2023 | $469.08 M(-205.0%) | $469.08 M(-8.5%) |
| Sept 2023 | - | $512.69 M(-199.8%) |
| June 2023 | - | -$513.54 M(+14.9%) |
| Dec 2022 | -$446.85 M | -$446.85 M(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -$394.71 M(+7.8%) |
| Mar 2022 | - | -$366.02 M(+12.5%) |
| Dec 2021 | -$325.22 M(+244.6%) | - |
| Dec 2021 | - | -$325.22 M(+8.2%) |
| Sept 2021 | - | -$300.45 M(+218.3%) |
| Dec 2020 | -$94.38 M(>+9900.0%) | -$94.38 M |
| Dec 2019 | -$21.00 K | - |
FAQ
- What is Neumora Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Neumora Therapeutics?
- What is Neumora Therapeutics annual shareholders equity year-on-year change?
- What is Neumora Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly shareholders equity year-on-year change?
What is Neumora Therapeutics annual stockholders equity?
The current annual shareholders equity of NMRA is $469.08 M
What is the all time high annual shareholders equity for Neumora Therapeutics?
Neumora Therapeutics all-time high annual stockholders equity is $469.08 M
What is Neumora Therapeutics annual shareholders equity year-on-year change?
Over the past year, NMRA annual stockholders equity has changed by +$915.93 M (+204.97%)
What is Neumora Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NMRA is $320.74 M
What is the all time high quarterly shareholders equity for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly stockholders equity is $512.69 M
What is Neumora Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, NMRA quarterly stockholders equity has changed by -$103.80 M (-24.45%)